Karl Arnberg und Zitiert - Info zur Person

(1 - 3 von 6

)

Acceptance Godman Persson et al docThe University of Liverpool

livrepository.liverpool.ac.uk

von B Godman · · Zitiert von: 43 — The authors would like to acknowledge the help of Karl Arnberg (TLV) for his helpful comments especially regarding potential follow-on studies.

Determinants of utilisation differences for cancer medicines ...JSTOR

www.jstor.org

von A Ferrario · · Zitiert von: 4 — Mr Karl Arnberg, Dr Elena Nicod, Dr Panos Kanavos for their feedback on previous versions of this article, and Professor Alistair.

The Impact of Disease Severity and Cost EffectivenessRePEc

econpapers.repec.org

von M Svensson · · Zitiert von: 127 — By Mikael Svensson, Fredrik Nilsson and Karl Arnberg; Abstract: The TLV places substantial weight on both the cost effectiveness and the ... von M Svensson · · Zitiert von: 127 — Karl Arnberg. Registered: · Mikael Svensson. Abstract. The TLV places substantial weight on both the cost effectiveness and the severity ...

Verwandte Suchanfragen zu Karl Arnberg

Personen
Vorname "Karl" (41379)
Name "Arnberg" (55)

sortiert nach Relevanz / Datum

Erweiterte Suche

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Karl Arnberg und Zitiert Person-Info

Acceptance Godman Persson et al docThe University of Liverpool

Determinants of utilisation differences for cancer medicines ...JSTOR

The Impact of Disease Severity and Cost EffectivenessRePEc